Myeloma bone marrow plasma cells: Evidence for their capacity as antigen-presenting cells

Blood

Volumn 90, Issue 5, 1997, Pages 1960-1967

  Yi, Qing ^a   Dabadghao, Sunil ^a   Österborg, Anders ^a   Bergenbrant, Susanne ^a   Holm, Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW BIOPSY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL;

EID: 0030884240     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.5.1960     Document Type: Article

References (39)

1. Mellstedt H, Holm G, Björkholm M: Multiple myeloma, Waldenström's macroglobulinemia, and benign monoclonal gammopathy: Characteristics of the B cell clone, immunoregulatory cell populations and clinical implications. Adv Cancer Res 41:257, 1984
2. Kyle R: Diagnostic criteria of multiple myeloma. Hematol Oncol Clin North Am 6:347, 1992
3. Moscinski L, Ballester OF: Recent progress in multiple myeloma. Hematol Oncol 12:111, 1994
4. Klein B, Zhang X-G, Lu Z-Y, Bataille R: Interleukin-6 in human multiple myeloma. Blood 85:863, 1995
5. Duperray C, Klein B, Durie BGM, Zhang X, Jourdan M, Poncelet P, Favier F, Vincent C, Brochier J, Lenoir G, Bataille R: Phenotypic analysis of human myeloma cell lines. Blood 73:566, 1989
6. Elsässer D, Valerius T, Repp R, Weiner GJ, Deo Y, Kalden JR, van de Winkel JGJ, Stevenson GT, Glennie MJ, Gramatzki M: HLA class II as potential target antigen on malignant B cells for therapy with bispecific antibodies in combination with granulocyte colony-stimulating factor. Blood 87:3803, 1996
7. + is the common phenotype of myeloma cells. Ann Hematol 64:132, 1992
8. Barker HF, Hamilton MS, Ball J, Drew M, Franklin IM: Expression of adhesion molecules IFA-3 and N-CAM on normal and malignant human plasma cells. Br J Haematol 81:331, 1992
9. Kawano MK, Huang N, Harada H, Sakai A, Tanaka H, Iwato K, Kuramoto A: Identification of immature and mature myeloma cells in the bone marrow of human myelomas. Blood 82:564, 1993
10. Westendorf JJ, Ahmann GJ, Armitage RJ, Spriggs MK, Lust JA, Greipp PR, Katzmann JA, Jelinek DF: CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line. J Immunol 152:117, 1994
11. Pellat-Deceunynck C, Bataille R, Robillard N, Harousseau J-L, Rapp M-J, Juge-Morineau N, Wijdenes J, Amiot M: Expression of CD28 and CD40 in human myeloma cells: A comparative study with normal plasma cells. Blood 84:2597, 1994
12. Urashima M, Chauhan D, Uchiyama H, Freeman GJ, Anderson K: CD40 ligand triggered interleukin-6 secretion in multiple myeloma. Blood 85:1903, 1995
13. Epstein J, Hoover R, Kornbluth, Barlogie B: Biological aspects of multiple myeloma. Clin Haematol 8:721, 1995
14. van Camp B, Thielemans C, Dehou MF, de Mey J, de Waele M: Two monoclonal antibodies (OKIa and OKT10) for the study of the final B cell maturation. J Clin Immunol 2:67S, 1982
15. Anderson KC, Bates MP, Slaughenhoupt, B Schlossman SF, Nadler LM: A monoclonal antibody with reactivity restricted to normal and neoplastic plasma cells. J Immunol 132:3172, 1984
16. Omedé P, Boccadoro M, Fusaro A, Gallone G, Pileri A: Multiple myeloma: 'Early' plasma cell phenotype identifies patients with aggressive biological and clinical characteristics. Br J Haematol 85:504, 1993
17. Pilarski LM, Jensen GS: Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am 6:297, 1992
18. Ruiz-Aggüelles GJ, San Miguel JF: Cell surface markers in multiple myeloma. Mayo Clin Proc 69:684, 1994
19. Harada Y, Kawano MM, Huang N, Mahmoud MS, Lisukov IA, Mihara K, Tsujimoto T, Kuramoto A: Identification of early plasma cells in peripheral blood and their clinical significance. Br J Haematol 92:184, 1996
20. Yi Q, Holm G, Lefvert AK: Idiotype-induced T cell stimulation requires antigen presentation in association with HLA-DR molecules. Clin Exp Immunol 104:359, 1996
21. Yi Q, Bergenbrant S, Österborg A, Ösby E, Östman R, Björkholm M, Holm G, Lefvert AK: T-cell stimulation induced by idiotypes on monoclonal immunoglobulins in patients with monoclonal gammopathies. Scand J Immunol 38:529, 1993
22. Yi Q, Österborg A, Bergenbrant S, Mellstedt H, Holm G, Lefvert AK: Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies. Blood 86:3043, 1995
23. Lee K-C, Wong M, Spitzer D: Chloroquine as a probe for antigen processing by accessory cells. Transplantation 34:150, 1982
24. Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O, Tanaka H, Sakai A, Asaoku H, Kuramoto A: Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 81:2658, 1993
25. Germain RN: MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation. Cell 76:287, 1994
26. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation. Cell 81:979, 1995
27. Linsley PS, Brady W, Grosmaire L, Aruffo A, Damle NK, Ledbetter JA: Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721, 1991
28. Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM: Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 90:11059, 1993
29. Freeman GJ, Borriello F, Hodes RJ, Reiser H, Hathcock KS, Laszio G, McKnight AJ, Kim J, Du L, Lombard DB, Gray GS, Nadler LM, Sharpe AH: Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science 262:907, 1993
30. Unanue ER, Allen PM: The basis for the immunoregulatory role of macrophages and other accessory cells. Science 236:551, 1987
31. Goebels N, Michaelis D, Wekerle H, Hohlfeld R: Human myoblasts as antigen-presenting cells. J Immunol 149:661, 1992
32. Croft M, Bradley LM, Swain SL: Native versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J Immunol 152:2675, 1994
33. + subsets. Br J Haematol 96:338, 1997
34. Österborg A, Yi Q, Henriksson L, Fagerberg J, Bergenbrant S, Lefvert AK, Holm G, Mellstedt H: Idiotype immunization in combination with GM-CSF of myeloma patients induced a CD8 T cell response and tumor regression. Blood 88:585a, 1996 (abstr, suppl 1)
35. Kupfer A, Singer SJ: Cell biology of cytotoxic and helper T cell functions: Immunofluorescence microscopic studies of single cells and cell couples. Annu Rev Immunol 7:309, 1989
36. Cardoso AA, Schultze JL, Boussiotis VA, Freeman GJ, Seamon MJ, Laszlo S, Billet A, Sallan SE, Gribben JG, Nadler LM: Pre-B acute lymphoblastic leukemia cells may induce T-cell anergy to alloantigen. Blood 88:41, 1996
37. Nakagomi H, Petersson M, Magnusson I, Juhlin C, Matsuda M, Mellstedt H, Taupin J-L, Vivier E, Anderson P, Kiessling R: Decreased expression of the signal-transducing ξ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma. Cancer Res 53:5610, 1993
38. Massaia M, Attisano C, Beggiato E, Bianchi A, Pileri A: Correlation between disease activity and T-cell CD3 ξ chain expression in a B-cell lymphoma. Br J Haematol 88:886, 1994
39. Schwartz RH: Models of T cell anergy: Is there a common molecular mechanism? J Exp Med 184:1, 1996